РАК ШЕЙКИ МАТКИ. ФАКТОРЫ РИСКА И ПРОФИЛАКТИКА
Keywords:
рак шейки матки, вирус папилломы человека, табакокурение, никотин, прогрессирование заболевания.
Abstract
В данной статье рассматриваются актуальные вопросы онкологии – роль табака в возникновении и развитии плоскоклеточного рака шейки матки. Представлены материалы, доказывающие влияние табакокурения, также пассивного курения в прогрессии плоскоклеточного рака на течение заболевания, на результаты различных видов лечения и прогноз, возможные пути профилактики.
References
Ferlay J., Shin H., Bray F. et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127(12):2893−917.
2. Aleksandrova I.N, Lyshchev A.A, Safronnikova N.R. et al. Papillomavirus infection in healthy women from St.Petersburg. Vopr Onkol 2000; 46(2):175−9.
3. Belinson J., Qiao Y.L., Pretorius R. et al. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001;83 (2):439−44. Erratum in: Gynecol Oncol 2002 ;84 (2):355.
4. Blumenthal P.D., Gaffikin L., Chirenje Z.M. et al. Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear. Int J Gynaecol Obstet 2001;72 (1):47−53.
5. Clavel C., Masure M., Bory J.P. et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 2001;84(12):1616−23.
6. Lazcano-Ponce E., Herrero R., Muñoz N. et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001 ;91(3):412−20.
7. Matos E., Loria D., Amestoy G.M. et al. Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study. Sex Transmis Dis 2003;30(8):593−9.
8. Sellors J.W., Maony J.B., Kaczorowski J. et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ 2000;163 (5):503−8.
9. Schiffman M., Castle P.E. Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med 2003;127 (8):930−4.
10. Wiley D.J., Douglas J., Beutner K. et al. External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis 2002;35 (suppl 2):210−24.
11. Muñoz N., Bosch F.X., de Sanjosé S. et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348 (6):518−27.
12. Clifford G.M., Smith J.S., Aguado T., Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003;89(1):101−5.
13. Jansen K.U., Shaw A.R. Human papillomavirus vaccines and prevention of cervical cancer. Annu Rev Med 2004;55:319−31.
14. Clifford G.M., Smith J.S., Plummer M. et al.Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88 (1):63−73.
15. Walboomers J.M., Jacobs M.V., Manos M.M. et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 1999; 189 (1):1−3.
16. Baay M.F., Verhoeven V., Avonts D., Vermorken J.B. Risk factors for cervical cancer development: what do women think? Sex Health.2004;1(3):145−9.
17. Castle P.E., Wacholder S., Lorincz A.T. et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirusinfected women. J Natl Cancer Inst 2002;94 (18):1406−14.
18. Goodman A., Wilbur D.C. Case 32-2003: A 37 year-old woman with atypical squamous cells on a papanicolaou smear. N Engl J Med.. 2003;349 (16):1555−64.
19. Bory J.P., Cucherousset J., Lorenzato M. et al. Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: a longitudinal study of 3,091 women. Int J Cancer 2002;102 (5):519−25.
20. Ho G.Y., Bierman R., Beardsley L. et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338 (7):423−8.
21. Nobbenhuis M.A., Helmerhorst T.J., van den Brule A.J. et al. Cytological regression ,and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet 2001 ;358 (9295):1782−3.
22. Koutsky L.A., Ault K.A., Wheeler C.M. et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002;347(21):1645−51.
23. Harper D.M., Franco E.L., Wheeler C. et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial. Lancet 2004 ;364(9447):1757−65.
24. McCann M.F., Irwin D.E., Walton L.A. et al. Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. Cancer Epidemiol Biomarkers Prev 1992;1(2):125−9.
25. International Collaboration of Epidemiological Studies of Cervical Cancer. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006;118(6):1481−95.
26. Roteli-Martins C.M., Panetta K., Alves Vam Siqueira S.A. et al. Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. Cancer Epidemiol Biomarkers Prev 1992;1(2):125−9.
27. Ho G.Y., Kadish A.S., Burk R.D. et al. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int J Cancer 1998 ;78(3):281−5.
28. McIntyre-Seltman K., Castle P.E., Guido R. et al.ALTS Group. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers Prev 2005;14(5):1165−70.
29. Szarewski A., Jarvis M.J., Sasieni P. et al. Effect of smoking cessation on cervical lesion size. Lancet.1996 ;348 (9028):682−3.
30. Kucera H., Enzelsberger H., Eppel W., Weghaupt K. The influence of nicotine abuse and diabetes mellitus on the results of primary irradiation in the treatment of carcinoma of the cervix. Cancer. .1987 ;60(1):1−4.
31. Fyles A., Voduc D., Syed A. et al. The effect of smoking on tumour oxygenation and treatment outcome in cervical cancer. Clin Oncol (R Coll Radiol) 2002;14(6):442−6.
32. Waggoner S.E., Darcy K.M., Fuhrman B. et al. Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: A Gynecologic Oncology Group study. Gynecol Oncol. In press 2006.
34. Рузибоева Ёркиной Равшановна, Каримов Азизбек Равшанбекович //Факторы, предрасполагающие к развитию рака шейки матки среди женьщин Ферганской области за период 2017-2021гг// Международный научно-практический журнал “Интернаука”. Вып №12 (235) 2022. 31-32 page
35. M.T.Mamatqulova, Y.R.Rosibayeva, S.T.Yulchieva, H.A.Rakhimova //Pregnancy During a Pandemic of Coronavirus Infektion Covid-19 Risks and Effects on the Unborn Child// 2023 International Conferense February 19-23, San Francisco, CA. record number #4222350
2. Aleksandrova I.N, Lyshchev A.A, Safronnikova N.R. et al. Papillomavirus infection in healthy women from St.Petersburg. Vopr Onkol 2000; 46(2):175−9.
3. Belinson J., Qiao Y.L., Pretorius R. et al. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001;83 (2):439−44. Erratum in: Gynecol Oncol 2002 ;84 (2):355.
4. Blumenthal P.D., Gaffikin L., Chirenje Z.M. et al. Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear. Int J Gynaecol Obstet 2001;72 (1):47−53.
5. Clavel C., Masure M., Bory J.P. et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 2001;84(12):1616−23.
6. Lazcano-Ponce E., Herrero R., Muñoz N. et al. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001 ;91(3):412−20.
7. Matos E., Loria D., Amestoy G.M. et al. Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study. Sex Transmis Dis 2003;30(8):593−9.
8. Sellors J.W., Maony J.B., Kaczorowski J. et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ 2000;163 (5):503−8.
9. Schiffman M., Castle P.E. Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med 2003;127 (8):930−4.
10. Wiley D.J., Douglas J., Beutner K. et al. External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis 2002;35 (suppl 2):210−24.
11. Muñoz N., Bosch F.X., de Sanjosé S. et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348 (6):518−27.
12. Clifford G.M., Smith J.S., Aguado T., Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003;89(1):101−5.
13. Jansen K.U., Shaw A.R. Human papillomavirus vaccines and prevention of cervical cancer. Annu Rev Med 2004;55:319−31.
14. Clifford G.M., Smith J.S., Plummer M. et al.Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003;88 (1):63−73.
15. Walboomers J.M., Jacobs M.V., Manos M.M. et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 1999; 189 (1):1−3.
16. Baay M.F., Verhoeven V., Avonts D., Vermorken J.B. Risk factors for cervical cancer development: what do women think? Sex Health.2004;1(3):145−9.
17. Castle P.E., Wacholder S., Lorincz A.T. et al. A prospective study of high-grade cervical neoplasia risk among human papillomavirusinfected women. J Natl Cancer Inst 2002;94 (18):1406−14.
18. Goodman A., Wilbur D.C. Case 32-2003: A 37 year-old woman with atypical squamous cells on a papanicolaou smear. N Engl J Med.. 2003;349 (16):1555−64.
19. Bory J.P., Cucherousset J., Lorenzato M. et al. Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: a longitudinal study of 3,091 women. Int J Cancer 2002;102 (5):519−25.
20. Ho G.Y., Bierman R., Beardsley L. et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338 (7):423−8.
21. Nobbenhuis M.A., Helmerhorst T.J., van den Brule A.J. et al. Cytological regression ,and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet 2001 ;358 (9295):1782−3.
22. Koutsky L.A., Ault K.A., Wheeler C.M. et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002;347(21):1645−51.
23. Harper D.M., Franco E.L., Wheeler C. et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial. Lancet 2004 ;364(9447):1757−65.
24. McCann M.F., Irwin D.E., Walton L.A. et al. Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. Cancer Epidemiol Biomarkers Prev 1992;1(2):125−9.
25. International Collaboration of Epidemiological Studies of Cervical Cancer. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006;118(6):1481−95.
26. Roteli-Martins C.M., Panetta K., Alves Vam Siqueira S.A. et al. Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers. Cancer Epidemiol Biomarkers Prev 1992;1(2):125−9.
27. Ho G.Y., Kadish A.S., Burk R.D. et al. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int J Cancer 1998 ;78(3):281−5.
28. McIntyre-Seltman K., Castle P.E., Guido R. et al.ALTS Group. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Biomarkers Prev 2005;14(5):1165−70.
29. Szarewski A., Jarvis M.J., Sasieni P. et al. Effect of smoking cessation on cervical lesion size. Lancet.1996 ;348 (9028):682−3.
30. Kucera H., Enzelsberger H., Eppel W., Weghaupt K. The influence of nicotine abuse and diabetes mellitus on the results of primary irradiation in the treatment of carcinoma of the cervix. Cancer. .1987 ;60(1):1−4.
31. Fyles A., Voduc D., Syed A. et al. The effect of smoking on tumour oxygenation and treatment outcome in cervical cancer. Clin Oncol (R Coll Radiol) 2002;14(6):442−6.
32. Waggoner S.E., Darcy K.M., Fuhrman B. et al. Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: A Gynecologic Oncology Group study. Gynecol Oncol. In press 2006.
34. Рузибоева Ёркиной Равшановна, Каримов Азизбек Равшанбекович //Факторы, предрасполагающие к развитию рака шейки матки среди женьщин Ферганской области за период 2017-2021гг// Международный научно-практический журнал “Интернаука”. Вып №12 (235) 2022. 31-32 page
35. M.T.Mamatqulova, Y.R.Rosibayeva, S.T.Yulchieva, H.A.Rakhimova //Pregnancy During a Pandemic of Coronavirus Infektion Covid-19 Risks and Effects on the Unborn Child// 2023 International Conferense February 19-23, San Francisco, CA. record number #4222350
Published
2023-11-23
How to Cite
Ё.Р.Рузибаева, М.Т.Маматкулова, & А.С.Борецкая. (2023). РАК ШЕЙКИ МАТКИ. ФАКТОРЫ РИСКА И ПРОФИЛАКТИКА. Central Asian Journal of Medical and Natural Science, 4(6), 695-703. Retrieved from https://cajmns.casjournal.org/index.php/CAJMNS/article/view/2092
Section
Articles
